D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$591M |
| 2 |
NVIDIA
NVDA
|
+$454M |
| 3 |
EQT Corp
EQT
|
+$361M |
| 4 |
Citigroup
C
|
+$332M |
| 5 |
CELG
Celgene Corp
CELG
|
+$315M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$618M |
| 2 |
Dell
DELL
|
+$463M |
| 3 |
IBM
IBM
|
+$331M |
| 4 |
Amgen
AMGN
|
+$284M |
| 5 |
Johnson & Johnson
JNJ
|
+$250M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 13.01% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Financials | 10.39% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Collegium Pharmaceutical
COLL
$1.23B
| $2.81M | ﹤0.01% |
109,972
-117,300
| -52% | -$3M |
|
1302
Oceaneering
OII
$2.48B
| $2.81M | ﹤0.01% |
151,341
-15,823
| -9% | -$293K |
|
1303
Bath & Body Works
BBWI
$5.75B
| $2.8M | ﹤0.01% |
90,765
-250,673
| -73% | -$7.74M |
|
1304
Adient
ADNT
$2B
| $2.8M | ﹤0.01% |
46,816
-189,042
| -80% | -$11.3M |
|
1305
Cerus
CERS
$240M
| $2.79M | ﹤0.01% |
509,997
-158,598
| -24% | -$869K |
|
1306
Atkore
ATKR
$2.09B
| $2.79M | ﹤0.01% |
140,680
+18,642
| +15% | +$370K |
|
1307
NMI Holdings
NMIH
$3.13B
| $2.79M | ﹤0.01% |
168,630
-52,485
| -24% | -$869K |
|
1308
National Health Investors
NHI
$3.76B
| $2.79M | ﹤0.01% |
41,414
+25,479
| +160% | +$1.71M |
|
1309
TG Therapeutics
TGTX
$5.15B
| $2.78M | ﹤0.01% |
195,524
+107,253
| +122% | +$1.52M |
|
1310
Darden Restaurants
DRI
$24.9B
| $2.77M | ﹤0.01% |
32,461
-45,538
| -58% | -$3.88M |
|
1311
SM Energy
SM
$3.13B
| $2.77M | ﹤0.01% |
153,462
-265,998
| -63% | -$4.8M |
|
1312
Digi International
DGII
$1.35B
| $2.77M | ﹤0.01% |
268,531
-9,516
| -3% | -$98K |
|
|
CSW
1313
CSW Industrials, Inc.
CSW
$4.28B
| $2.76M | ﹤0.01% |
61,159
-428
| -0.7% | -$19.3K |
|
1314
Newell Brands
NWL
$2.55B
| $2.75M | ﹤0.01% |
108,105
-955,832
| -90% | -$24.4M |
|
1315
Vanda Pharmaceuticals
VNDA
$272M
| $2.75M | ﹤0.01% |
163,275
-3,117
| -2% | -$52.5K |
|
1316
MasterCraft Boat Holdings
MCFT
$378M
| $2.73M | ﹤0.01% |
108,232
+7,257
| +7% | +$183K |
|
|
GHDX
1317
DELISTED
Genomic Health, Inc.
GHDX
| $2.73M | ﹤0.01% |
87,156
-30,133
| -26% | -$943K |
|
|
SGY
1318
DELISTED
Stone Energy
SGY
| $2.73M | ﹤0.01% |
73,447
+63,558
| +643% | +$2.36M |
|
1319
Titan International
TWI
$558M
| $2.71M | ﹤0.01% |
215,259
+7,003
| +3% | +$88.3K |
|
1320
Calavo Growers
CVGW
$496M
| $2.71M | ﹤0.01% |
29,345
+10,872
| +59% | +$1M |
|
1321
Banco Santander Chile
BSAC
$12.5B
| $2.7M | ﹤0.01% |
80,685
-65,540
| -45% | -$2.2M |
|
|
UCB
1322
United Community Banks, Inc.
UCB
$3.97B
| $2.7M | ﹤0.01% |
85,173
-43,426
| -34% | -$1.37M |
|
1323
AngioDynamics
ANGO
$445M
| $2.69M | ﹤0.01% |
156,122
-18,670
| -11% | -$322K |
|
1324
Mueller Industries
MLI
$10.9B
| $2.69M | ﹤0.01% |
205,776
+101,710
| +98% | +$1.33M |
|
1325
ePlus
PLUS
$1.99B
| $2.69M | ﹤0.01% |
69,196
-6,002
| -8% | -$233K |
|